Literature DB >> 34879221

Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.

Bola S Hanna1, Laura Llaó-Cid2, Murat Iskar3, Philipp M Roessner3, Lara C Klett4, John K L Wong3, Yashna Paul3, Nikolaos Ioannou5, Selcen Öztürk3, Norman Mack3, Verena Kalter3, Dolors Colomer6, Elías Campo6, Johannes Bloehdorn7, Stephan Stilgenbauer7, Sascha Dietrich8, Manfred Schmidt9, Richard Gabriel9, Karsten Rippe4, Markus Feuerer10, Alan G Ramsay5, Peter Lichter3, Marc Zapatka3, Martina Seiffert11.   

Abstract

T cell exhaustion limits anti-tumor immunity and responses to immunotherapy. Here, we explored the microenvironmental signals regulating T cell exhaustion using a model of chronic lymphocytic leukemia (CLL). Single-cell analyses identified a subset of PD-1hi, functionally impaired CD8+ T cells that accumulated in secondary lymphoid organs during disease progression and a functionally competent PD-1int subset. Frequencies of PD-1int TCF-1+ CD8+ T cells decreased upon Il10rb or Stat3 deletion, leading to accumulation of PD-1hi cells and accelerated tumor progression. Mechanistically, inhibition of IL-10R signaling altered chromatin accessibility and disrupted cooperativity between the transcription factors NFAT and AP-1, promoting a distinct NFAT-associated program. Low IL10 expression or loss of IL-10R-STAT3 signaling correlated with increased frequencies of exhausted CD8+ T cells and poor survival in CLL and in breast cancer patients. Thus, balance between PD-1hi, exhausted CD8+ T cells and functional PD-1int TCF-1+ CD8+ T cells is regulated by cell-intrinsic IL-10R signaling, with implications for immunotherapy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T cells; CLL; IL-10; IL-10R; NFAT; PD-1 heterogeneity; STAT3; T cell exhaustion; TCF-1; tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 34879221     DOI: 10.1016/j.immuni.2021.11.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  11 in total

1.  Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels.

Authors:  Xiaozeng Lin; Yan Gu; Yingying Su; Ying Dong; Pierre Major; Anil Kapoor; Damu Tang
Journal:  Cancers (Basel)       Date:  2022-06-05       Impact factor: 6.575

2.  A T cell resilience model associated with response to immunotherapy in multiple tumor types.

Authors:  Yu Zhang; Trang Vu; Douglas C Palmer; Rigel J Kishton; Lanqi Gong; Jiao Huang; Thanh Nguyen; Zuojia Chen; Cari Smith; Ferenc Livák; Rohit Paul; Chi-Ping Day; Chuan Wu; Glenn Merlino; Kenneth Aldape; Xin-Yuan Guan; Peng Jiang
Journal:  Nat Med       Date:  2022-05-02       Impact factor: 87.241

Review 3.  Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics.

Authors:  Emanuela Guerra; Roberta Di Pietro; Mariangela Basile; Marco Trerotola; Saverio Alberti
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

Review 4.  STAT3 pathway in cancers: Past, present, and future.

Authors:  Han-Qi Wang; Qi-Wen Man; Fang-Yi Huo; Xin Gao; Hao Lin; Su-Ran Li; Jing Wang; Fu-Chuan Su; Lulu Cai; Yi Shi; Bing Liu; Lin-Lin Bu
Journal:  MedComm (2020)       Date:  2022-03-23

5.  Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy.

Authors:  Justin Harper; Susan P Ribeiro; Chi Ngai Chan; Malika Aid; Claire Deleage; Luca Micci; Maria Pino; Barbara Cervasi; Gopalan Raghunathan; Eric Rimmer; Gulesi Ayanoglu; Guoxin Wu; Neeta Shenvi; Richard Jo Barnard; Gregory Q Del Prete; Kathleen Busman-Sahay; Guido Silvestri; Deanna A Kulpa; Steven E Bosinger; Kirk A Easley; Bonnie J Howell; Dan Gorman; Daria J Hazuda; Jacob D Estes; Rafick-Pierre Sekaly; Mirko Paiardini
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

6.  Immunologic Gene Sets Reveal Features of the Tumor Immune Microenvironment and Predict Prognosis and Immunotherapy Response: A Pan-Cancer Analysis.

Authors:  Hongda Pan; Jingxin Pan; Pei Li; Jianghong Wu
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

7.  Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer Cases.

Authors:  Xiaobao Cheng; Jian Hou; Xiangyang Wen; Runan Dong; Zhenquan Lu; Yi Jiang; Guoqing Wu; Yuan Yuan
Journal:  J Oncol       Date:  2022-09-06       Impact factor: 4.501

8.  Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.

Authors:  Taotao Liang; Xiaojiao Wang; Yanyan Liu; Hao Ai; Qian Wang; Xianwei Wang; Xudong Wei; Yongping Song; Qingsong Yin
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

9.  A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy.

Authors:  Shengfu He; Jiawen Yu; Weijie Sun; Yating Sun; Mingyang Tang; Bao Meng; Yanyan Liu; Jiabin Li
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

10.  WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer.

Authors:  Wenting Du; Rosa E Menjivar; Katelyn L Donahue; Padma Kadiyala; Ashley Velez-Delgado; Kristee L Brown; Hannah R Watkoske; Xi He; Eileen S Carpenter; Christina V Angeles; Yaqing Zhang; Marina Pasca di Magliano
Journal:  J Exp Med       Date:  2022-10-14       Impact factor: 17.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.